CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 133 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 40 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -88.9% | 40 | -92.6% | 0.00% | -100.0% |
| Q4 2020 | $9,000 | +800.0% | 540 | +1250.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 40 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 40 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,388,967 | $125,425,669 | 9.68% |
| 5AM Venture Management, LLC | 497,270 | $18,403,963 | 4.12% |
| COMMODORE CAPITAL LP | 1,425,000 | $52,739,250 | 3.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 374,910 | $13,875,419 | 3.27% |
| TSP Capital Management Group, LLC | 249,220 | $9,223,635 | 2.89% |
| Eventide Asset Management | 3,327,132 | $123,137,155 | 2.11% |
| Affinity Asset Advisors, LLC | 475,400 | $17,594,554 | 2.03% |
| Novo Holdings A/S | 850,000 | $31,458,500 | 1.83% |
| Bellevue Group AG | 2,971,615 | $109,979,471 | 1.79% |
| Redmile Group, LLC | 718,723 | $26,599,938 | 1.61% |